Biogen Pharmachem Reports Nil Unutilised Issue Proceeds as of Sep'26
Biogen Pharmachem Industries Ltd 路 Others (Uncategorized) 路 03 Nov 2026, 8:56 pm
Biogen Pharmachem Reports Nil Unutilised Issue Proceeds as of Sep'26 Biogen Pharmachem Industries Limited submitted its disclosure under Regulation 32(1) of SEBI LODR Regulations to BSE on 3rd Nov'26. The company confirmed that it has no unutilised funds remaining as of 30th Sep'26 or as of the filing date from any previous public issues, rights issues, preferential issues, or qualified institutional placements (QIPs). Consequently, no statement of deviation or variation was required under Annexure-A.
Original exchange filing (PDF)
More announcements from Biogen Pharmachem Industries Ltd
- PFA 路 03 Nov 2026
- Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors .... 路 03 Nov 2026
- Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Pursuant to .... 路 03 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rama Shiva Lease Finance Pvt Ltd 路 23 Oct 2026
- PFA 路 30 Sept 2026
- PFA 路 29 Sept 2026
- Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial .... 路 04 Sept 2026
- PFA 路 04 Sept 2026
